Afinitor (everolimus) is a targeted therapy used to treat several types of cancer and non-cancerous tumors by inhibiting the mTOR protein, which slows cell growth and blood vessel formation. It is commonly used for advanced hormone-receptor-positive breast cancer, neuroendocrine tumors, advanced kidney cancer, and tumors associated with tuberous sclerosis complex.
